Generic EPO Competition Arrives in Europe

More bad news for Amgen and J&J yesterday when the European Union's health authorities approved a generic version of erythropoietin made by Novartis.

If folks up on Capitol Hill are looking for ways to raise money to pay for the children's health insurance bill, they should consider passing a generic biologics bill and allow sale of that drug here.